Articleposted 2024-10-21 09:41:08
Predicting survival in prospective clinical trials using weakly-supervised QSP
Vincent Lemaire, Matthew West, Kenta Yoshida, Jiajie Yu
Under Revision
at
Articleposted 2024-06-11 18:37:44
Early Noninvasive Tracking of Response to Targeted Therapy in Non-Small Cell Lung Cancer
Hatim Husain, Kevin Lu, Brian Woodward, Ruby Singhrao, Manana Javey, Hans-Peter Adams, Ulrich Schlecht, and 2 more authors
Posted
at
Articleposted 2024-03-15 06:24:12
CasRx-Based Kras G12D Silencing for In Vivo Tumor Inhibition in Spontaneous Lung Adenocarcinoma
Xiaojing Wang, Fei Liu, Lingling Xu, Yan Shi, Linxiang Zhang, Fuliang Chen, Shihui Gu, and 10 more authors
Posted
at
Articleposted 2023-09-29 17:40:33
Genomic and immune heterogeneity of multiple synchronous lung adenocarcinoma at different developmental stages
Haiquan Chen, Yue Zhao, Jian Gao, Jun Wang, Fanfan Fan, Chao Cheng, Danwen Qian, and 22 more authors
Published
at
Articleposted 2023-08-11 14:10:11
Structural insights into epitope-paratope interactions of monoclonal antibody targeting CEACAM5-expressing tumors
Alexey Rak, Anand Kumar, Francis Duffi, Marie Gagnaire, Chiara Rapisarda, Thomas Bertrand
Under Review
at
Articleposted 2023-07-28 18:22:42
From Pixels to Insights: Unveiling Spatial Immune Associations of Immunotherapy Response in Non-Small Cell Lung Cancer using Multiplexed Tissue Imaging
Arutha Kulasinghe, James Monkman, Afshin Moradi, Joseph Yunis, Geoffrey Ivison, Aaron Mayer, Rahul Ladwa, and 1 more authors
Posted
at
Brief Communicationposted 2023-03-22 02:40:01
Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer
Aadel Chaudhuri, Nicholas Semenkovich, Pamela Samson, Shahed Badiyan, Gregory Vlacich, Hayley Stowe, Yun Wang, and 6 more authors
Published
at
Articleposted 2023-03-01 06:02:10
Mechanistic insight into sex differences in lung cancer induced by cRaf
Shen Zhong, Jürgen Borlak
Posted
at
Articleposted 2022-11-23 17:50:19
Impact of TMB, PD-L1 expression, and pneumonitis on outcomes to chemoradiation and durvalumab in unresectable stage III non-small cell lung cancers
Emily Lebow, Narek Shaverdian, Mark Awad, Bruce Johnson, Daniel Gomez, Jamie Chaft, Adam Schoenfeld, and 10 more authors
Published
at